Clinical trials are a key tool for advancing medical knowledge and patient
care. It is only with educational institutions, pharmaceutical companies,
device manufacturers, physicians and volunteer patients that the medical
field is able to improve and advance new treatments and methods of care.
Through discoveries made with clinical trials physicians gain knowledge
to help determine the safety and effectiveness of new care methods that
can present new possibilities for patients.
While being involved in clinical trials of new medications inherently
has some risk, taking part in a clinical trial can have several benefits.
For patients, it can give subjects access to new treatments before they're
widely available; and if a new treatment is shown to work that patient
might be among the first to benefit by being part of the trial and then
an extension trial. This is particularly important because many people
who volunteer for trials are not satisfied with their current treatments.
Even if a patient is part of a study that does not lead to better treatments
or new care methods, and results show that doctors are already doing what
is best, the patient is still helping and challenging researchers to come
up with new ideas to study the disease or condition. All participants
of trials help to contribute to scientific knowledge and are vital to
the advancement of medicine. Many patients volunteer for trials because
they want to help others, take control of their medical condition, and
try alternative treatments.
"Patients often find remarkable satisfaction in helping others to
find promising treatments by participating in clinical trials," say
Dr. Daniel Nadeau, Program Director of the Mary & Dick Allen Diabetes
Center, Dr. Kris V. Iyer Endowed Chair in Diabetes Care and Endocrinologist
at Hoag Medical Group.
TheMary and Dick AllenDiabetes Center andHoag Medical Group are both currently
participating in a number of clinical trials for diabetes, Hepatitis C
and HIV. Current trials include:
Type 2 diabetes: long-acting insulin combined with lixisenatide (a GLP-1)Hepatitis
C interferon-free treatment study for patients co-infected with Hepatitis
C and HIVSeveral HIV and Hepatitis C treatment studiesHIV study for patients
interested in switching therapiesIf you feel you would be a good candidate
for one of these trials or you would like more information on the trials
please contact Kathy Shea, Clinical Research Program Manager at 949-791-3017
or [email protected]
For more information regarding services at The Mary & Dick Allen Diabetes
Center, please call 949-764-8065 or visitwww.hoag.org/diabetes and for
more information about Hoag Medical Group, visitwww.HoagMedicalGroup.com.